Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece)

被引:128
作者
Maltezou, H. C. [1 ]
Giakkoupi, P. [2 ]
Maragos, A. [1 ]
Bolikas, M. [3 ]
Raftopoulos, V. [1 ]
Papahatzaki, H. [3 ]
Vrouhos, G. [4 ]
Liakou, V. [3 ]
Vatopoulos, A. C. [2 ]
机构
[1] Hellen Ctr Dis Control & Prevent, Dept Intervent Health Care Facil, Athens, Greece
[2] Natl Sch Publ Hlth, Dept Microbiol, Athens, Greece
[3] Venizeleio Gen Hosp, Dept Microbiol, Iraklion, Greece
[4] Venizeleio Gen Hosp, Intens Care Unit, Iraklion, Greece
关键词
KPC; Carbapenemase; Resistance; Nosocomial outbreak; Klebsiella pneumoniae; Tigecycline; Colistin; HYDROLYZING BETA-LACTAMASE; KPC-2; ISOLATE; TIGECYCLINE; SPP;
D O I
10.1016/j.jinf.2009.01.010
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Starting in May 2007, an ongoing outbreak of infections due to carbapenem resistant KPC-2-producing Klebsiella pneumoniae occurred in a tertiary care hospital in Crete (Greece). The outbreak involved 22 patients, none of whom had travelled in a country with known high prevalence of such isolates. KPC-producing K. pneumoniae strains were mainly isolated from patients admitted in the Intensive Care Unit, on mechanical ventilation, with prolonged hospitalization, prolonged administration of antibiotics, and prolonged administration of carbapenems. Clinical diagnoses were: pneumonia (62% of cases), surgical site infection (19%), bacteremia (9.5%), urinary tract infection (4.7%), and peritonitis (4.7%). Overall, 61 KPC-producing K. pneumoniae isolates were recovered, mainly from the respiratory tract (59.1%), catheter tip (22.7%), surgical site (18.2%), and blood (18.2%). Among 16 patients for whom therapeutic data were available, 14 (87.5%) were treated with a combination of colistin and/or tigecycline and/or garamycin. Clinical failure was noted in 22.2% of 18 patients available for assessment of clinical outcome, and microbiologic failure in 87.5% of 8 patients available for assessment of microbiologic outcome. In conclusion, an outbreak of KPC-producing K. pneumoniae infections has occurred in a tertiary care hospital in Greece, with significant associated morbidity and mortality. Prospective studies are required to evaluate the available therapeutic options for these infections. Our efforts should focus on rational use of available antibiotics, enhancement of infection control measures, and implementation of active antibiotic resistance surveillance. (C) 2009 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:213 / 219
页数:7
相关论文
共 31 条
[1]   Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City [J].
Bradford, PA ;
Bratu, S ;
Urban, C ;
Visalli, M ;
Mariano, N ;
Landman, D ;
Rahal, JJ ;
Brooks, S ;
Cebular, S ;
Quale, J .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (01) :55-60
[2]   Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York [J].
Bratu, S ;
Landman, D ;
Alam, M ;
Tolentino, E ;
Quale, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (02) :776-778
[3]   Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City -: A new threat to our antibiotic armamentarium [J].
Bratu, S ;
Landman, D ;
Haag, R ;
Recco, R ;
Eramo, A ;
Alam, M ;
Quale, J .
ARCHIVES OF INTERNAL MEDICINE, 2005, 165 (12) :1430-1435
[4]   Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-β-lactamase-producing enterobactefiaceae:: Report from the SENTRY antimicrobial surveillance program [J].
Castanheira, Mariana ;
Sader, Helio S. ;
Deshpande, Lalitagauri M. ;
Fritsche, Thomas R. ;
Jones, Ronald N. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :570-573
[5]   Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement [J].
Chopra, Ian ;
Schofield, Christopher ;
Everett, Martin ;
O'Neill, Alex ;
Miller, Keith ;
Wilcox, Mark ;
Frere, Jean-Marie ;
Dawson, Mike ;
Czapiewski, Lloyd ;
Urleb, Uros ;
Courvalin, Patrice .
LANCET INFECTIOUS DISEASES, 2008, 8 (02) :133-139
[6]  
Clinical and Laboratory Standards Institute, 2007, M100S17 CLSI
[7]  
Conly Jm, 2006, Can J Infect Dis Med Microbiol, V17, P267
[8]   Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece [J].
Cuzon, Gaelle ;
Naas, Thierry ;
Demachy, Marie Claude ;
Nordmann, Patrice .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (02) :796-797
[9]   Tigecycline for treatment of pneumonia and empyema caused by carbapenemase-producing Klebsiella pneumoniae [J].
Daly, Michael W. ;
Riddle, David J. ;
Ledeboer, Nathan A. ;
Dunne, W. Michael ;
Ritchie, David J. .
PHARMACOTHERAPY, 2007, 27 (07) :1052-1057
[10]  
*EUR SURV ANT CONS, COUNTR SHEET GREEC